Product information

From Health Canada

New search

The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.

Current status:

Marketed

Current status date:

2020-09-10

Original market date: See footnote 1

2017-12-14

Product name:

FOQUEST

Help on accessing alternative formats, such as Portable Document Format (PDF), Microsoft Word and PowerPoint (PPT) files, can be obtained in the alternate format help section .

DIN:

02470349

Product Monograph/Veterinary Labelling:

Date: 2020-08-20 Product monograph/Veterinary Labelling (PDF version ~ 175K)

Company: 

ELVIUM LIFE SCIENCES
575 Granite Court
Pickering
Ontario
Canada  L1W 3W8

Class: 

Human

Dosage form(s):

Capsule (Controlled Release)

Route(s) of administration:

Oral

Number of active ingredient(s):

1

Schedule(s):

Schedule G (CDSA III)  

Biosimilar Biologic Drug:

No

American Hospital Formulary Service (AHFS): See footnote 3

28:20.32   Respiratory and CNS Stimulants

Anatomical Therapeutic Chemical (ATC): See footnote 4

N06BA04  METHYLPHENIDATE

Active ingredient group (AIG) number:See footnote 5

0107548013

List of active ingredient(s)
Active ingredient(s) Strength
METHYLPHENIDATE HYDROCHLORIDE 85 MG

Application information

Related information

Contact us

Version 3.8.0
Date modified: